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To prevent the spread of pathogens neutrophils as the first line of defense are able to release
Neutrophil Extracellular Traps (NETs), a recently discovered form of immune response.
Reactive oxygen species (ROS) have been shown to be essential for many different induc-
tion routes of NET formation. Therefore, pharmacological inhibition of ROS generation has
implications for research and medicine related to NETs. The application of diphenylene
iodonium (DPI), an inhibitor of NADPH oxidase activity, is limited due to its toxicity to
host cells as well as microbes. Therefore, we investigated the effect of 4-hydroxy-2,2,6,6-
tetramethylpiperidine-1-oxyl (Tempol) a membrane-permeable radical scavenger on NET
formation triggered by phorbol esters and Candida albicans. We quantified the amount
of NETs with two complementary methods, using a microscopic analysis and an online
fluorescence-based assay. In line with removal of ROS, Tempol reduced the amount of
NET formation by neutrophils challenged with those stimuli significantly. SinceTempol effi-
ciently blocks NET formation in vitro, it might be promising to test the effect of Tempol in
experimental models of disorders in which NETs probably have hazardous effects.
Keywords: neutrophils, neutrophil extracellular traps, reactive oxygen species, nitroxide,Tempol, NET inhibition
INTRODUCTION
Polymorphonuclear neutrophils (PMNs) are circulating leuko-
cytes and serve as a first line of defense against microbial infections,
but are at the same time a main contributor to hazardous effects
during inflammation (Nathan, 2006). In humans, approximately
2× 1011 neutrophils are produced per day (Borregaard, 2010).
These professional phagocytes contain a large reservoir of antimi-
crobial proteins, which they secrete or release into the phagosome
containing engulfed microbes (Amulic et al., 2012). The cells
express the phagocyte NADPH oxidase complex which enables
them to produce superoxide (Segal et al., 2012). The superox-
ide anion is converted spontaneously or enzymatically driven to
other Reactive Oxygen Species (ROS). The exposure to antimicro-
bial proteins and ROS concertedly kills the phagocytosed microbe
(Nathan, 2006).
Neutrophil Extracellular Traps (NETs) have been described
as an extracellular mechanism of neutrophils to trap and kill
microbes (Brinkmann et al., 2004). NETs consist of nuclear chro-
matin decorated with antimicrobial proteins. ROS are required
to form NETs, as neutrophils from chronic granulomatous dis-
ease (CGD) patients, unable to form ROS, do not release NETs
(Fuchs et al., 2007). NETs can be induced by various stimuli, such
as bacteria, fungi, parasites chemokine IL-8, and protein kinase
C activation via Phorbol Myristate Acetate (PMA; Brinkmann
et al., 2004; Guimaraes-Costa et al., 2009; Urban et al., 2009; Mar-
cos et al., 2010; Parker et al., 2012). As a consequence of NET
release upon these stimuli the neutrophil plasma membrane rup-
tures and thus, per definition, the NET-releasing cell dies (Fuchs
et al., 2007). Other studies proposed alternative mechanisms of
DNA trap release that is catapult-like and involves the release of
mitochondrial instead of nuclear DNA from viable neutrophils
(Yousefi et al., 2009). Staphylococcus aureus seems to be able to
induce NET formation by triggering the neutrophils to expel their
nuclei packaged in vesicles leaving the plasma membrane intact
(Pilsczek et al., 2010; Yipp et al., 2012). These findings illustrate
the complexity of the process of NETosis and therefore the urgent
need for better tools to study the underlying mechanisms in more
detail.
Apart from their positive role during infection by preventing
dissemination of microbes (Yipp et al., 2012), NETs are assumed
to have hazardous effects as well. Thus, NETs may also contribute
to harm the host during uncontrolled inflammatory processes.
For instance, NETs have been described to be involved in autoim-
mune and inflammatory disorders, such as Small-Vessel Vasculitis
(SVV; Kessenbrock et al., 2009; Nakazawa et al., 2012), Systemic
Lupus Erythematosus (SLE; Hakkim et al., 2010b; Villanueva et al.,
2011; Leffler et al., 2012), amyloidoses (Azevedo et al., 2012), and
in Transfusion-induced Acute Lung Injury (TRALI; Caudrillier
et al., 2012; Thomas et al., 2012). Treatment with vitamin C
reduced the load of NETs during experimental TRALI in mice
(Caudrillier et al., 2012). This in particular indicates that potential
NET inhibitors could prove valuable in medical applications for
diseases where NET formation is involved.
Since a significant proportion of described NET release mech-
anisms depend on ROS (Hakkim et al., 2010a), any molecule that
prevents the generation of ROS or drives their metabolism should
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be able to inhibit the release of ROS-dependent NETs. There-
fore, we reasoned that the ROS metabolizing compound Tempol
(4-hydroxy-tetramethylpiperidin-1-oxyl) is able to interfere with
NET formation. This low molecular weight compound is a sta-
ble, membrane-permeable redox-cycling nitroxide, mimetic to the
super oxide dismutase (SOD) enzyme by scavenging superoxide
radicals (Krishna et al., 1996). The great advantage of Tempol for
any potential medical application is its very low toxicity in mam-
mals (Wilcox, 2010). Other compounds that directly block ROS
production, e.g., by inhibiting flavin enzymes of the NADPH oxi-
dase complex or myeloperoxidase, such as diphenyleneiodonium
(DPI) and sodium azide respectively, are either unspecific or toxic
to cells (Riganti et al., 2004). Tempol can metabolize a variety of
ROS and protect cells (Hahn et al., 1992) and animals (Goffman
et al., 1992) from radiation damages.
To test the effect of Tempol on NET formation we used three
different stimuli to induce NETosis: PMA, which has been shown
to be ROS-dependent (Fuchs et al., 2007), the fungal pathogen
Candida albicans, a physiological stimulus that also requires ROS
(Ermert et al., 2009), and finally the chemokine IL-8, which has
been suggested to induce NET formation ROS-independently
(Marcos et al., 2010). For this purpose, the ROS production as
well as the amount of netting neutrophils at different time points
were determined microscopically and confirmed with an online
fluorescence-based assay quantifying extracellular DNA or in more
general terms cell death.
We show here that Tempol efficiently removes ROS produced
by human neutrophils upon PMA and C. albicans stimulation,
without negatively affecting phagocytic function of neutrophils.
NET formation was inhibited by Tempol in a dose-dependent
manner. PMA and C. albicans-induced NET formation efficiently
as expected, whereas IL-8 did not trigger significant amounts of
NETs. This study introduces Tempol as a valuable candidate com-




Neutrophils were harvested from blood of healthy volunteers
according to the recommendations of the local ethical committee
(Regionala etikprövningsnämnden i Umeå) as approved in permit
Dnr 09-210M. Fully informed consent was obtained, and all inves-
tigations were conducted according to the principles expressed
in the Declaration of Helsinki. The isolation of neutrophils was
performed as described previously (Fuchs et al., 2007). Briefly,
neutrophils were separated from blood with two gradient centrifu-
gation steps. The first one uses Histopaque 1119 (Sigma-Aldrich)
to remove red blood cells while the second one uses discontin-
uous gradients of percoll (Amersham) that separate neutrophils
from monocytes, lymphocytes, and residual red blood cells. Subse-
quently, the cells were washed with 1× PBS+ 0.5% human serum
albumin (HSA) and resuspended in RPMI 1640 medium without
phenol red (Lonza).
CULTURE OF C. ALBICANS
An overnight culture of C. albicans (SC5314) was inoculated in
YPD from a culture dish. After incubation the culture was diluted
to a starting OD600 of 0.1 in fresh growth medium. To grow C.
albicans in its yeast form the cells were incubated in YPD at 30˚C
for 4 h. To produce hyphae the same dilution was used in RPMI
medium and the cell suspensions were incubated at 37˚C for 4 h.
The multiplicity of infection (MOI) for C. albicans hyphae was
adjusted to the initial number of yeast cells that were used for
inoculation, since under these conditions almost 100% filamenta-
tion can be expected. The factor 3× 107 cells/ml at OD600 of 1 was
used to convert the number of yeast cells in the logarithmic phase
to the number of hyphae.
LUMINOL ASSAY
Neutrophil ROS production was determined by luminol biolumi-
nescence as described previously (Ermert et al., 2009). Briefly, cells
were seeded in a white 96 well plate at a concentration of 5× 104
cells per well. Twenty microliters of Tempol in different concen-
trations or RPMI were added and the cells incubated for 15 min
at 37˚C. For the assay, luminol (Sigma-Aldrich) and horseradish
peroxidase (Sigma-Aldrich) were added to a final concentration
of 50µM and 1.2 U/ml respectively. NET formation was induced
just before starting the assay by the addition of PMA at final con-
centration of 100 nM, yeast or hyphae of C. albicans at an MOI of
3, or human recombinant IL-8 at a final concentration of 100 nM
(Abcam). ROS were measured by luminescence catalysis in a Tecan
Infinite 200 plate reader every 3 min for a period of 3 h.
CELL DEATH ASSAY
Neutrophil cell death or presence of extracellular DNA was mea-
sured by fluorescence with Sytox Green (Invitrogen) similar to
previous descriptions (Fuchs et al., 2007; Ermert et al., 2009).
Briefly, cells were seeded in a black 96 well plate with a con-
centration of 5× 104 cells per well in a total volume of 160µl.
Subsequently, Tempol was added in different concentrations and
plates were incubated for 15 min at 37˚C. After this short incu-
bation, Sytox Green, a membrane-impermeable DNA dye, was
added to a final concentration of 2.5µM, before cells were stimu-
lated with PMA (100 nM final concentration), C. albicans yeast or
hyphae (both MOI 3) or IL-8 (100 nM). The samples were mon-
itored for fluorescence under cell culture conditions (37˚C, 5%
CO2) in a plate-based fluorescence spectrophotometer (Fluostar
Omega, BMG) in intervals of 10 min for a total of 10 h. Per-
cent NET formation was calculated as percentage of lysis control.
From this value, percent cell death of unstimulated neutrophils
was subtracted at the respective time points. Data were presented
as percent cell death.
PHAGOCYTOSIS ASSAY
Neutrophil phagocytosis was measured by using pHrodo S. aureus
bioparticles according to the manufacturer’s protocol (Invitro-
gen). This assay is based on increased fluorescence of the beads
upon acidification in the phagosome.
Briefly, cells were seeded in a white 96 well plate at a concen-
tration of 5× 104 cells per well and pHrodo S. aureus BioParticles
were added at a final concentration of 25µg/well in a total volume
of 150µl. Samples containing Cytochalasin D (Sigma-Aldrich) at
a final concentration of 10µg/ml and incubated for 15 min at 37˚C
to block phagocytosis served as a negative control. As 100% con-
trol BioParticles in buffer at pH 4 were used. Tempol or RPMI
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was added at different concentrations. Plates were measured in
a fluorescence spectrophotometer (Fluostar Omega, BMG) every
30 min for 2 h.
CHEMOTAXIS ASSAY FOR HUMAN NEUTROPHILS USING TRANSWELL
INLETS
To test bioactivity of human recombinant IL-8 (Abcam) neu-
trophil migration was measured in a transwell system. The neu-
trophils were labeled with a fluorescent cytoplasmic dye, BCECF-
AM (Sigma-Aldrich) at a final concentration of 3.3µM and
5× 105 neutrophils were seeded on a fluorescence-impermeable
transwell membrane (BD Falcon, HTS FluoroBlok Insert, 3.0µM
pore size). The transwell was placed into a 24-well tissue culture
plate (BD Falcon) just before measurement. The lower compart-
ment of the tissue culture plate contained 600µl of RPMI with
0.05% HSA and 10 nM human recombinant IL-8 was added as
chemoattractant. For base line migration the lower compartment
contained medium only. As 100% control served 5× 105 BCECF-
AM labeled neutrophils without inserting the transwell system.
The samples were monitored for fluorescence under cell culture
conditions (37˚C, 5% CO2) in a fluorescence spectrophotometer
(Fluostar Omega, BMG) in intervals of 1 min for a total of 10 min.
Chemotaxis was plotted as percentage of total signal and base line
signal was subtracted.
IMMUNOSTAINING OF NEUTROPHILS
Cells were seeded on cover slips coated with 0.01% poly-l-lysine
(Sigma-Aldrich) in 24-well plates with a concentration of 1× 105
cells per well in a total volume of 500µl. Tempol was added
to a final concentration of 30 mM and incubated for 15 min.
Subsequently, cells were induced with PMA (100 nM final con-
centration) C. albicans yeast or hyphae (MOI 3) or IL-8 (100 nM)
for 3 and 6 h at 37˚C and 5% CO2. After incubation the cells were
fixed using paraformaldehyde (2% final concentration) for 30 min
at RT. Specimens were stored at 4˚C. For immune staining the cover
slips were washed three times with PBS and permeabilized with
0.5% TritonX-100 (Merck) in PBS. Cells were blocked at 37˚C
for 1 h in blocking buffer containing 3% cold water fish gelatin
(Sigma-Aldrich), 1% gelatin from bovine serum (Sigma-Aldrich),
5% donkey serum (Jackson Immuno research), and 0.25% Tween
20 (VWR). Antibodies directed against histone H1 (1.25µg/ml;
#BM465, Acris) and directed against neutrophil elastase (6µg/ml;
#481001, Calbiochem) were used and incubated for 1 h at 37˚C.
Secondary antibodies conjugated to Cyanine dyes (Cy 2 and Cy 3,
Jackson Immuno research) were used. DNA was stained with DAPI
and washed one time with double distilled water. Specimens were
mounted in Mowiol 4-88 (Calbiochem) and images were captured
using a 20× objective (Nikon 90i fluorescence microscope). The
neutrophil elastase staining was confirmatory to validate the pres-
ence of NETs and is not presented here. Images were analyzed with
NIS-Elements analysis software ver. 3.20.
MICROSCOPIC QUANTIFICATION OF NETS
We adapted previously described methods for NET quantification
microscopically, such as Ermert et al. (2009), Papayannopoulos
et al. (2010), Keshari et al. (2012), Parker et al. (2012). Microscopic
image analysis was performed using histone immune-stained sam-
ples including five random images and counting at least 400 cells
from each condition. ImageJ version 1.44p software was used to
measure pixel areas by adjusting the threshold above background.
Measured pixel areas were converted toµm2 (With 200-fold mag-
nification 472 pixels equal 100µm2). Particles comprising an area
of less than 15µm2 were excluded from analysis. Human neu-
trophils have an average diameter of 10µm, hence their average
area in an unstimulated stage is approximately 80µm2 (assuming
a circle and using pi× r2). To quantify the number of cells that
underwent NET formation we chose signal events that exceeded
100µm2 and thus were larger than the whole intact cell area.
Events larger than 100µm2 were either considered as decondensed
nuclei, an essential step prior to NETosis, or as released NETs.
The total number of cells was counted and NET-forming cells
were expressed as percentages of events larger than 100µm2 from
the total number of events. Three independent experiments using
neutrophils from three different donors were analyzed for each
sample.
STATISTICAL ANALYSIS
Tukey one-way ANOVA was applied for statistical analysis of the
data using the software GraphPad Prism v 5.00.
FIGURE 1 |Tempol reduces NET formation stimulated by PMA. Indirect
immunofluorescence of PMA-stimulated PMNs (100 nM) for 6 h in the
presence or absence of Tempol (30 mM). Unstimulated PMNs and PMNs
incubated with Tempol only served as control. NET formation is visualized
after fixation using staining of chromatin with a primary antibody directed
against histone H1 and a Cy-3 conjugated secondary antibody. The
representative microscopic images illustrate unstimulated PMNs (A),
PMNs stimulated with PMA (B), PMNs treated with Tempol (C), and PMNs
treated with Tempol and stimulated with PMA (D). NETs are indicated by
arrows, decondensed nuclei with filled arrow heads. Open arrow heads
show intact PMNs. Images were captured with a Nikon Eclipse 90i
microscope and a Hamamatsu Orca-ER charge-coupled device camera
using a 40× objective. Scale bar: 10µm.
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RESULTS
TEMPOL SCAVENGES ROS PRODUCED BY PMA-STIMULATED
NEUTROPHILS
Protein kinase C (PKC) stimulation by the phorbol ester PMA is a
well-known strong inducer of NET formation (Brinkmann et al.,
2004). PMA-induced NET formation has additionally been shown
FIGURE 2 |Tempol scavenges neutrophil ROS triggered by PMA. The
total amount of ROS generated by PMNs over the course of three 3 h is
plotted against increasing concentrations of Tempol. The half maximal
inhibitory concentration (IC50) is 0.2 mM Tempol. ROS amounts were
calculated as area under the curve (AUC). White bar: unstimulated PMNs,
black bar: PMNs stimulated with 100 nM PMA, grey bars: PMNs treated
with different concentration of Tempol prior to stimulation with PMA.
Significance was analyzed by Tukey one-way ANOVA (*P ≤0.05 and
***P ≤0.001). One representative experiment out of three independent
experiments with three different donors is shown. Data are presented as
means of three technical replicates ±SD.
to be ROS-dependent (Fuchs et al., 2007). Therefore, we tested
the ROS scavenger Tempol for inhibition of NET formation. We
stimulated neutrophils with PMA that have either been previously
incubated with Tempol or with culture medium only. We analyzed
the samples by microscopic immunofluorescence as described in
Materials and Methods. After 6 h of incubation we observed NET
formation in the mock-treated specimen. Patchy, web-like struc-
tures were present that stained positive for histone, a major com-
ponent of NETs, and decondensation of nuclear chromatin could
be observed (Figure 1). Decondensation of neutrophil nuclei is
a hallmark of NET formation and occurs previous to the release
of NETs (Fuchs et al., 2007). In contrast, the Tempol-treated neu-
trophils formed significantly less NETs and the majority of nuclei
were lobulated indicating that they were still intact (Figure 1).
Thus, we concluded that Tempol has NET-inhibitory activity.
First, we aimed to identify adequate concentrations of Tempol
to remove ROS produced by neutrophils. For this purpose, we
induced neutrophils with PMA in the presence of different con-
centrations of Tempol and subsequently measured the amount of
ROS produced in a luminol-based plate assay. Tempol at a con-
centration of 0.2 mM removed approximately 50%, 1 mM 75%
and 10 mM more than 90% of PMA-induced ROS (Figure 2).
Thus, Tempol was able to remove PMA-induced neutrophil ROS
efficiently and in a dose-dependent manner.
TEMPOL INHIBITS PMA-INDUCED ROS-DEPENDENT NET FORMATION
We next investigated the effect of Tempol on NET formation in a
quantitative manner. To unambiguously determine NET forma-
tion we chose a microscopic approach. Neutrophils were stim-
ulated with PMA in the presence of 0, 15, or 30 mM Tempol
and then fixed after 3 and 6 h, respectively. The cells were labeled
with an anti-histone antibody and analyzed by immunofluores-
cence microscopy. We adapted previously described methods to
quantify NET formation microscopically, such as Ermert et al.
(2009), Papayannopoulos et al. (2010), Keshari et al. (2012), Parker
et al. (2012). Determining the area occupied by intact cells or
NETs – as expressed in µm2 – respectively, provides an appro-
priate measure to distinguish NETs from intact or non-NETotic
dead neutrophils and thereby representing a means to assay NET
FIGURE 3 |Tempol prevents PMA-induced NET formation. Microscopic
evaluation of NET formation by PMNs stimulated with 100 nM PMA reveals
reduced formation of NETs in the presence of Tempol. Percentage of NET
formation after 3 h (A) and after 6 h (B). White bars: unstimulated PMNs,
dashed gray bars: PMNs treated with Tempol only (30 mM), black bars: PMNs
stimulated with PMA, gray bars: Tempol-treated PMNs stimulated with PMA.
The percentage of cells undergoing NET formation was computed by using
ImageJ as explained in materials and methods. Significance was analyzed by
Tukey one-way ANOVA (**P ≤0.01 and ***P ≤0.001). Data are presented as
means±SD of three independent experiments with three different donors.
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formation in a quantitative manner (see Materials and Meth-
ods). Using this microscopic approach we determined that 40%
of PMA-stimulated neutrophils underwent NETosis after 3 h and
70% after 6 h (Figure 3). Notably, 30 mM Tempol reduced NET
formation significantly to 15% after 3 h and to 30% after 6 h
(Figure 3). Background levels of NETs from unstimulated neu-
trophils were usually around 20% after 6 h of incubation. In
conclusion, Tempol treatment reduced PMA-induced NET forma-
tion to background levels, comparable to unstimulated neutrophils
(Figure 3B).
To confirm these results with a microscopy-independent assay,
we used a fluorescence-based cell death assay (CDA) taking advan-
tage of the fact that the plasma membrane ruptures during NET
release (Ermert et al., 2009). Neutrophils were treated with PMA
in the presence of the membrane-impermeable DNA dye Sytox
Green, only detecting extracellular DNA or DNA that is not sur-
rounded by an intact membrane. The samples were monitored
for fluorescence under cell culture conditions. NET formation was
calculated as percentage of lysis control (equaling 100%) and addi-
tionally, background levels from unstimulated neutrophils were
subtracted (see Materials and Methods).
In accordance to the microscopic analysis, Tempol reduced
PMA-induced NET formation, as indicated by a decrease in flu-
orescence in the corresponding samples (Figure 4A). To be able
to directly compare these results to the microscopic analysis, we
extracted the values at 3 and 6 h from these measurements, respec-
tively. The effect of Tempol was dose-dependent resulting in less
than 10% cell death after 3 h (Figure 4B) and 20% cell death
at 15 mM as well as 15% cell death at 30 mM Tempol after 6 h
(Figure 4C). A specific mode of action for Tempol in reduc-
ing NET release is therefore highly probable. Notably, Tempol
even decreased spontaneous cell death in the unstimulated con-
trol as verified by the same assay up to concentrations of 100 mM,
clearly demonstrating that Tempol has very low toxicity at these
concentrations (Figure A1 in Appendix).
Taken together both the microscopic analysis and CDA con-
firmed that Tempol is able to block NET formation efficiently.
Moreover, both assays resulted in highly similar levels of NET
formation by PMA-stimulated neutrophils, suggesting that both
assays are suitable to quantify NET formation.
TEMPOL SCAVENGES ROS PRODUCED BY C. ALBICANS -STIMULATED
NEUTROPHILS
Since PMA is a very potent, however non-physiological stimu-
lus of NET formation, we used C. albicans to induce NETosis
in neutrophils representing the most frequent fungal pathogen
in humans. C. albicans is dimorphic (Sudbery et al., 2004) and
both growth forms, yeast cells as well as filamentous hyphae are
able to trigger NET formation by neutrophils (Urban et al., 2006).
Therefore, we included both growth morphologies in this study.
To identify the Tempol concentrations which are sufficient to
remove neutrophil ROS triggered by C. albicans and consequently
potentially abolish NET formation, we measured ROS production
in the presence of 0 mM up to 30 mM Tempol in the infection
assays (Figure 5). Ten millimolar Tempol reduced yeast-triggered
neutrophil ROS down to 2.5% of the amount produced in the
absence of Tempol. ROS were further reduced in a dose-dependent
FIGURE 4 |Tempol prevents PMA-induced NET formation quantified by
cell death assay. Tempol reduces PMN cell death in a dose-dependent
manner. The rate of cell death of PMNs stimulated with the highly potent
NET-inducer PMA in the presence or absence of Tempol was analyzed over
a period of 10 h by measurement of DNA-staining by the cell-impermeable
dye Sytox Green. (A) TheY -axis represents the relative amount of dead
cells after normalization to the lysis control (100%). Background values
(unstimulated cells) were subtracted from all values. To allow better
comparison with microscopic analyses, the effect of Tempol on
PMA-induced PMN cell death after stimulation for 3 h (B) and 6 h (C) is
additionally depicted as bar panels. (A) Black curve: PMNs stimulated with
100 nM PMA without Tempol treatment, gray curves: PMNs treated with
different concentrations of Tempol prior to stimulation with PMA.
Significance was analyzed by Tukey one-way ANOVA ***P ≤0.001). One
representative experiment out of three independent experiments with
three different donors is shown. Data are presented as means of three
technical replicates ±SD.
manner to 0.5% at 30 mM Tempol. Similarly, hyphae-triggered
ROS was reduced by Tempol, but with no further decrease at
30 mM Tempol. We concluded that 30 mM Tempol is sufficient
to efficiently remove C. albicans-induced neutrophil ROS.
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FIGURE 5 |Tempol scavenges neutrophil ROS triggered by
different growth forms of C. albicans. The total amount of ROS
generated by PMNs is plotted against increasing concentrations of
Tempol present in the culture medium. PMNs were infected with C.
albicans (MOI 3) in the presence of different concentrations of Tempol.
The total amount of ROS produced over 3 h was calculated as area
under the curve (AUC). PMNs infected with of C. albicans yeast (A)
and hyphal cells (B), respectively. White bars: unstimulated PMN, black
bars: PMNs infected with C. albicans, gray bars: PMNs treated with
different concentration of Tempol prior to stimulation with fungi.
Significance was analyzed by Tukey one-way ANOVA (***P ≤0.001).
One representative experiment out of three independent experiments
with three different donors is shown. Data are presented as means of
three technical replicates ±SD.
FIGURE 6 |Tempol prevents NET formation induced by different growth
forms of C. albicans. Microscopic evaluation of C. albicans infected PMNs
(MOI 3) demonstrates reduction of NET formation by Tempol. Percentage of
NET formation after infection with C. albicans yeast or hyphal cells for 3 h
(A) and 6 h (B). White bars: unstimulated PMNs, dashed gray bars: PMNs
treated with Tempol, black bars: PMNs stimulated with C. albicans yeast
growth form, gray bars: PMNs treated with Tempol prior to infection with
yeast, diagonal dashed black bars: PMNs stimulated with C. albicans
hyphae, diagonal dashed gray bars: PMNs treated with Tempol prior to
infection with hyphae. The percentage of cells undergoing NET formation
was calculated as explained in materials and methods. Significance was
analyzed by Tukey one-way ANOVA (**P ≤0.01 and ***P ≤0.001). Data are
presented as means ±SD of three independent experiments with three
different donors.
TEMPOL INHIBITS C. ALBICANS -INDUCED ROS-DEPENDENT NET
FORMATION
As C. albicans induces NET formation in a strictly ROS-dependent
manner (Ermert et al., 2009), we next investigated the effect of
Tempol on NET formation induced by the fungal pathogen using
the microscopic analysis described above. In these assays, yeasts
induced 35% NETs after 3 h and 45% after 6 h of incubation
(Figures 6A,B; solid bars). Thirty millimolar Tempol significantly
reduced NET formation at 3 h to approximately 10% and at 6 h
to 15% after stimulation with C. albicans yeasts. Similar results
were obtained when hyphae were used to trigger NET forma-
tion (Figures 6A,B; dashed bars). Tempol reduced NET formation
from 40% after 3 h and 65% after 6 h to 10 and 15%, respectively.
Consequently, 30 mM Tempol was able to reduce NET formation
induced by C. albicans yeast and hyphae to background levels.
To confirm the microscopic quantification we used the CDA
(Figure 7) as described for PMA-stimulated neutrophils. Upon
infection with yeast C. albicans, 40% neutrophil death was
observed (Figure 7A) and 45% neutrophil death upon hyphae
(Figure 7B) after 10 h of infection. To directly compare these
results to the microscopic analysis, we extracted the values at
3 and 6 h, respectively (Figures 7C–F). Yeast induced 10 and
20% cell death above background of unstimulated neutrophils
after 3 and 6 h, respectively (Figures 7C,E). Tempol at 15 and
30 mM reduced neutrophil cell death below 10% at all time
points (Figures 7C,E). When hyphae were used for infection we
observed 10% increase of neutrophil cell death above background
after 6 h (Figures 7D,F). Again, Tempol reduced neutrophil cell
death triggered by hyphae to 0%, indicating that Tempol inhibits
ROS-dependent NET formation.
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FIGURE 7 |Tempol prevents C. albicans-induced NET formation
quantified by cell death assay. Tempol reduces cell death during infection
with C. albicans. PMN cell death rates after infection with different growth
morphologies of C. albicans in the presence or absence of Tempol were
analyzed over a period of 10 h by measurement of DNA-staining by the
cell-impermeable dye Sytox Green. TheY -axis represents the relative amount
of dead cells after normalization to the lysis control (100%). Background
values (unstimulated cells) were subtracted from all values. PMN cell death
induced by the yeast (A) or the hyphal (B) growth form of C. albicans (MOI 3).
Black curves: PMNs infected with C. albicans, gray curves: PMNs infected
with C. albicans in the presence of different concentrations of Tempol. To
allow for better comparison with microscopic analyses, the effect of Tempol
on PMN cell death after infection with C. albicans at 3 h (C,D) and 6 h (E,F)
time points was compared in respect of the different cell morphotypes used.
Significance was analyzed by Tukey one-way ANOVA (NS: P >0.05,
**P ≤0.01, and ***P ≤0.001). One representative experiment out of three
independent experiments with three different donors is shown. Data are
presented as means of three technical replicates ±SD.
Taken together, the results from the microscopic quantification
and from the CDA are confirmatory and thus advantageous to
singular assays. As the CDA is much less laborious as the micro-
scopic analysis, this assay represents a valuable tool to quantify
NET formation in a simple and robust manner.
IL-8 AND C. ALBICANS CO-STIMULATION DOES NOT INCREASE NET
FORMATION BY HUMAN NEUTROPHILS
Since IL-8 was shown to prime neutrophils to produce more ROS
upon stimulation with the staphylococcal product fMLP (Brechard
et al., 2005), we aimed to elucidate whether treatment of neu-
trophils with IL-8 prior to infection with both morphotypes of C.
albicans additionally enhances neutrophil NET formation. How-
ever, IL-8 and C. albicans did not synergize to result in increased
NET formation as observed using the CDA (Figures 8A,B). The
bioactivity of recombinant IL-8 was confirmed with a neutrophil
chemotaxis assay showing that human neutrophils migrated sig-
nificantly toward the chemoattractant (Figure 8C). We also inves-
tigated the contribution of IL-8 alone to ROS production and
NET formation. We stimulated neutrophils with 100 nM IL-8 as
described previously (Marcos et al., 2010). Compared to PMA or
C. albicans, in our hands IL-8 did not induce significant amounts
of ROS and neither a significant increase in NET formation as
shown by microscopic analysis and the CDA (data not shown).
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FIGURE 8 | During infection with C. albicans IL-8 does not enhance
neutrophil NET formation. The rate of cell death of PMNs treated with
100 nM IL-8 for 30 min prior to infection with C. albicans (MOI 3) was
analyzed over a period of 10 h by measurement of DNA-staining by the
cell-impermeable dye Sytox Green. TheY -axis represents the relative
amount of dead cells after normalization to the lysis control (100%).
Background values (unstimulated cells) were subtracted from all values.
Black symbols: PMNs infected with yeast [(A), circles and triangles] or
hyphal cells [(B), squares and rhombuses] and additionally with IL-8
(triangles and rhombuses); gray symbols: PMNs additionally treated with
30 mM Tempol. One representative experiment out of three independent
experiments with three different donors is shown. Data are presented as
means of three technical replicates ±SD. Neutrophil chemotaxis was
measured in a transwell assay (C). TheY -axis represent the percentage of
neutrophil migration toward 10 nM IL-8 normalized to 100% florescent
labeled cells. The base line levels (migrated cells without chemoattractant)
were subtracted from all values. One representative experiment out of
three independent experiments with three different donors is shown. Data
are presented as means of three technical replicates ±SD.
DISCUSSION
We showed that Tempol removed neutrophil-produced ROS
effectively in a dose-dependent manner upon PMA and C. albicans
stimulation. For both stimuli ROS are essential to result in NET
formation. In line with this, Tempol reduced the amount of NET
release upon PMA and C. albicans stimulation. We confirmed
that Tempol effectively inhibits NETosis with two independent
quantitative assays, using a microscopic approach as well as a
fluorescence-based CDA. For PMA-stimulated NET formation
both assays correlated extremely well leading to similar results.
Using C. albicans as a physiological stimulus the microscopic
and cell death analyses diverged to a larger extent. Percentage
of NET release as determined microscopically was higher up to
6 h after infection with C. albicans as compared to neutrophil
cell death, as determined by detection of DNA no longer pro-
tected by a membrane. Since neutrophil cell death increased up
to 50% in later time points (up to 10 h), we assumed that there
might be a delay of NET release after decondensation of nuclei.
Decondensed nuclei are also classified as NETotic events in the
microscopic analysis, whereas nuclei decondense already within
an intact plasma membrane and, therefore, are not accessible to
the CDA. Additionally, in contrast to the microscopic analysis,
the background signal resulting from unstimulated neutrophils
was subtracted at any given time point in the CDA. To illus-
trate the observed effect more clearly we randomly selected two
more CDAs showing C. albicans infected neutrophils (Figure A2
in Appendix). Overall, neutrophil cell death is lower upon C. albi-
cans infection as compared to PMA stimulation, particularly when
hyphae are used. The absolute values for neutrophil cell death vary
the most for this microbial stimulus, probably due to donor vari-
ations and thus we did not combine independently performed
CDAs, but rather representative experiments. Usually, neutrophil
cell death upon infection with C. albicans yeast or hyphae ranges
from 25 to 50% after 10 h. Regardless, in each experiment we
detected NETs microscopically or by cell death and in both assays
Tempol significantly reduced the signal. In contrast to previous
findings, we did not observe a significant increase in NET forma-
tion upon IL-8 stimulation (Brinkmann et al., 2004; Marcos et al.,
2010).
In more recent publications it has been described that alive neu-
trophils release NETs either from their mitochondria or from the
nucleus both through an intact plasma membrane (Yousefi et al.,
2009; Yipp et al., 2012). These observations notwithstanding, our
findings are still valid for all different types of NET formation that
may coexist, as we microscopically validate the presence of NET
structures. Moreover, the CDA detects any extracellular DNA that
is released irrespective of the fate of the netting neutrophil, since
similar membrane-impermeable dyes were used in the mentioned
studies (Yousefi et al., 2009; Yipp et al., 2012).
The formation of NETs has been the focus of a large amount of
recent studies which addressed the role of these structures in health
and disease (Remijsen et al., 2011; Brinkmann and Zychlinsky,
2012). Evidence accumulates that NETs, besides their beneficial
role in infection, can also contribute to the pathogenesis of other
diseases affecting the immune system in a negative way, e.g., pro-
moting inflammation. The presence of NETs was reported for
instance for SLE (Hakkim et al., 2010b; Villanueva et al., 2011;
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Leffler et al., 2012), autoimmune SVV (Kessenbrock et al., 2009;
Nakazawa et al., 2012), allergic asthmatic airways (Dworski et al.,
2011), TRALI (Caudrillier et al., 2012; Thomas et al., 2012),
amyloidoses (Azevedo et al., 2012), and cancer (Demers et al.,
2012).
The emerging body of evidence for positive as well as nega-
tive NET-mediated effects on the health status of the host urge
us to search for compounds that are able to interfere with the
process of NET formation. A recent study attempted this by sys-
tematically screening for compounds that block NET formation.
The authors identified NADPH oxidase activation and the Raf-
MEK-ERK pathway to be crucial for NET formation (Hakkim
et al., 2010a). Since ROS are crucial for many, although certainly
not all, NET-inducing stimuli, we reasoned that any ROS inter-
fering compound may used to block NETs. Tempol displays low
toxicity in humans, as revealed by a clinical trial where Tempol
was applied as topical treatment in a concentration as high as
400 mM (Metz et al., 2004). Systemic administration of 150µl
of 150 mM Tempol in mice resulted in 8.1 mM Tempol in the
blood (Davis et al., 2010). Therefore, the amounts required for
blockage of NET formation in vitro ranging between 10 and
30 mM seem ambitious to be reached in vivo, since our in vitro
findings are 1.2- to 3.7-fold above this in vivo concentration. It
is very likely that in vivo additional factors influence NET for-
mation as compared to in vitro experiments. Therefore, future
experiments in animals will have to give evidence on whether
Tempol reduces NET formation in vivo. Application of Tempol
seems plausible, since the neutrophils in our assays were not
affected by Tempol concentrations as high as 100 mM (Figure A1
in Appendix). Furthermore, Tempol is indeed less toxic than
other compounds interfering directly with the activity of the
phagocyte oxidase complex, such as DPI (Riganti et al., 2004).
Therefore, it might be advantageous to remove ROS after pro-
duction and not to prevent their production at all. Since Tempol
is membrane-permeable, intracellular ROS, which are crucial sig-
naling molecules (Cap et al., 2012), might be removed and this in
turn could hamper signaling processes. Of note, we demonstrated
that Tempol treatment did not negatively affect phagocytosis of
neutrophils, but rather increase engulfment of staphylococcal par-
ticles (Figure A3 in Appendix). However, it might not be recom-
mendable to use Tempol in acute infections, since microbicidal
mechanisms of phagocytes are undoubtedly affected by removal
of ROS.
In conclusion, our study demonstrates that Tempol blocks
PMA- and Candida-triggered NET formation in vitro. These find-
ings suggest Tempol as a tool to study mechanisms of NET forma-
tion and may serve as a promising starting point to investigate the
potential of Tempol for the reduction of in vivo NET formation.
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APPENDIX
FIGURE A1 |Tempol alone is not toxic to human neutrophils. The rate of
cell death of PMNs stimulated with Tempol was analyzed over a period of
6 h by measurement of DNA-staining by the cell-impermeable dye Sytox
Green. TheY -axis represents the relative amount of dead cells after
normalization to the lysis control (100%). PMNs treated with Tempol in a
dose-dependent manner at time point 0 (A), after 3 h (B), and after 6 h (C).
Black bars: unstimulated PMNs, gray bars: PMNs treated with Tempol at
different concentrations. Significance was analyzed by Tukey one-way
ANOVA (NS: P >0.05). One representative experiment out of three
independent experiments with three different donors is shown. Data are
presented as means of three technical replicates ±SD.
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FIGURE A2 | Continued
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FIGURE A2 |Tempol prevents cell death induced by different growth
forms of C. albicans, additional representative results. The addition of
Tempol to the culture medium reduces cell death during infection with C.
albicans. The rate of cell death of PMNs infected with different growth forms
of C. albicans was analyzed over a period of 10 h by measurement of
DNA-staining by the cell-impermeable dye Sytox Green. TheY -axis represents
the relative amount of dead cells after normalization to the lysis control
(100%). Background values (unstimulated cells) were subtracted from all
values. Results are shown for two additional independent donors as rate of
PMN cell death induced by yeast (A,G) or hyphal cells (B,H) of C. albicans
(MOI 3). Black curves: PMNs infected with C. albicans, gray curves: PMNs
treated with different concentrations of Tempol. Increasing concentrations of
Tempol cause a reduction of PMN cell death upon infection with yeast (C,I) or
hyphal cells (D,J) for 3 h. Percentage of dead cells after 6 h upon infection
with yeast or (E,K) or hyphal cells of C. albicans (F,L). Significance was
analyzed by Tukey one-way ANOVA (NS: P >0.05, *P ≤0.05, **P ≤0.01, and
***P ≤0.001). Data are presented as means of three technical replicates
±SD.
www.frontiersin.org December 2012 | Volume 3 | Article 391 | 13
Hosseinzadeh et al. Tempol inhibits NETs
FIGURE A3 |Tempol enhances PMN phagocytosis of Staphylococcus
aureus bioparticles. The effect of Tempol on PMN phagocytosis was
analyzed using Staphylococcus aureus bioparticles. Cytochalasin D
treatment was used as a means to block PMN phagocytosis as a negative
control. Black bar: PMN phagocytosis without treatment was set as 1. Gray
bars: Fold change of PMN phagocytosis upon treatment with 15 mM
Tempol (dark gray) and 30 mM Tempol (light gray) as compared to untreated
cells. Significance was analyzed by Tukey one-way ANOVA (***P ≤0.001).
Data are presented as means from two independent experiments with
three technical replicates each ±SD.
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